Epidemiology
Congenital heart disease in a cohort of 19,502 births with long-term follow-up

https://doi.org/10.1016/0002-9149(78)90635-5Get rights and content

Abstract

The Child Health and Development Studies are longitudinal studies of pregnancy and the normal and abnormal development of the offspring. Women who were members of the Kaiser Foundation Health Plan entered the study in early pregnancy, and their children were examined frequently until the youngest child in the study was 5 years old. This is a more intensive follow-up than hitherto reported.

Of the 19,044 live-born children, 163 had definite and another 31 had possible congenital heart disease; the crude incidence rates per 1,000 live births were 8.8 for definite congenital heart disease and 10.4 for definite plus possible congenital heart disease. The incidence rate of congenital heart disease was 7.9 percent among all stillborn fetuses subjected to autopsy and 10.2 percent among those in this group with autopsies evaluated as being detailed enough to detect heart disease. Among the live-born children with congenital heart disease, 21 died in the neonatal period and 22 died in later infancy and childhood; about half the deaths were judged to have been due to heart disease. About 30 percent of the children with congenital heart disease had associated severe anomalies of other systems. In the whole cohort, 50 children had diagnosed chromosomal abnormalities (2.631,000live births) and about 30 percent of them had congenital heart disease. Among the group of 163 children with definite congenital heart disease, the diagnosis was made in 46 percent by age 1 week, in 88.3 percent by age 1 year and in 98.8 percent by age 4 years.

References (33)

  • J Yerushalmy

    The California Child Health and Development Studies. Study design and some illustrative findings on congenital heart disease

  • BJ Clawson

    Types of congenital heart disease in 15,597 autopsies

    J Lancet

    (1944)
  • HJ Hoffheinz et al.

    Über die Häufigkeit angeborener Herzfehler in Hamburger Sektionsgut

    Zentralbl Chir

    (1964)
  • JM Berg et al.

    Congenital cardiac malformations in mongolism

    Br Heart J

    (1960)
  • JP Bound et al.

    Incidence of congenital heart disease in Blackpool, 1957–1971

    Br Heart J

    (1977)
  • RH Feldt et al.

    Incidence of congenital heart disease in children born to residents of Olmstead County, Minnesota, 1950–1969

  • Cited by (468)

    • Role of Psychologists in Pediatric Congenital Heart Disease

      2022, Pediatric Clinics of North America
      Citation Excerpt :

      In a study by Reinhold-Richter and colleagues analyzing the autopsies of 3071 stillborn and deceased children younger than 16 years of age between 1969 and 1983, CHD was found in 26.5% of the autopsies.7 In another study by Hoffman and colleagues,8 the incidence of CHD in stillborn fetuses was 7.9%. There has been a significant increase in prevalence over the last century.

    • Percutaneous management of challenging complex resistive targets in interventional pediatric cardiology

      2022, Debulking in Cardiovascular Interventions and Revascularization Strategies: Between a Rock and the Heart
    • Prenatal diagnosis of congenital heart defects and voluntary termination of pregnancy

      2020, American Journal of Obstetrics and Gynecology MFM
      Citation Excerpt :

      Available studies indicate that TOP is requested mostly because of chromosomal aberrations, central nervous system anomalies, and multiple anomalies, suggesting that the likelihood of brain damage has a major impact on the decision of the couples.1,2 With an estimated prevalence of 6 to 7 cases per 1000 births, congenital heart defects (CHDs) are the most frequent malformations and encompass a wide range of complexity.3–6 Modern pediatric cardiology and cardiac surgery allow the treatment of even extreme malformations.

    View all citing articles on Scopus

    This study was supported by Grant HD 07256 of the National Institute of Child Health and Human Development of the National Institutes of Health, Bethesda, Maryland.

    View full text